Tom Wilemon

March 2, 2023

Eng invited to White House Cancer Moonshot forum

Vanderbilt’s Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
February 23, 2023

Trial seeks to expand therapies for biliary cancers

A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy.

By Tom Wilemon
February 16, 2023

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.

By Tom Wilemon
February 16, 2023

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt’s Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.

By Tom Wilemon
Krista Kuhnert-Gainer, ACNP, shows off the sign her colleagues made to celebrate her reaching 20,000 bone marrow biopsies performed.
February 9, 2023

‘Biopsy Queen’ reaches milestone number of procedures

Vanderbilt-Ingram Cancer Center’s Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.

By Tom Wilemon
The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
February 9, 2023

Vanderbilt-Ingram joins CancerLinQ quality initiative

Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.

By Tom Wilemon
February 6, 2023

Berlin named director of Division of Hematology and Oncology

Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.
By Tom Wilemon
January 19, 2023

Surgeons target pancreatic cancer with electrons using new technology

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
By Tom Wilemon
January 5, 2023

New approach outperforms existing cancer susceptibility models

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.
By Tom Wilemon
December 8, 2022

Lovly receives Asclepios Award from GO2 for Lung Cancer

Vanderbilt's Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.
By Tom Wilemon
November 16, 2022

Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis

Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis.
By Tom Wilemon
November 11, 2022

Study finds inherited link to appendix cancer

A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer.
By Tom Wilemon
1 … 6 7 8 9 10 … 37